Investment in senior housing and assisted living is doubling, but 2035 capital-need estimates range from €15bn to €23bn — a gap that says more about data uncertainty than the sector's real trajectory.
Italian real estate investment reached €2.8 billion in the first quarter of 2026, up 12% year on year, according to Gabetti Group's research office. Within that total, healthcare/RSA drew just over €200 million across only two deals — modest in absolute terms, but a figure Gabetti itself reads as a sign of growing institutionalisation in an early-stage segment. Zoom out to all of 2025 and the picture widens: per JLL and Nomisma data cited by Quotidiano Nazionale, the broader "Living" segment — senior housing plus student housing — pulled in €1.2 billion, up 40% on the prior year.
Capital is no longer coming only from small local players. Funds like Investire SGR now treat senior housing as a distinct, "counter-cyclical" asset class: its Spazio Blu pilot, developed with INPS, Gruppo CDP and Policlinico Gemelli for self-sufficient over-65s, is probably the clearest example of that institutionalisation in progress. On the demand side, the signal in major cities is clear: new senior-housing developments in Milan and Rome run near 95% occupancy. The picture for RSAs overall looks different — Antonio Fuoco, JLL Italy's head of Living Capital Markets, puts average national RSA bed occupancy at 78%, rising to 87% in Lombardy. A near-20-point gap between new-generation product and the existing stock, which says more about differentiated product quality than about uniform demand.
The demographic push behind this growing interest is well known, but the numbers still land hard up close. Istat's 2024-2050 projections put Italians over 65 at roughly 24% of the population today, rising to 34.5% by mid-century.
This is where the reasoning gets shakier. Estimates of capital needed by 2035 range from €15 billion to €23 billion — an €8 billion spread that says more about methodological uncertainty than about any settled trajectory. The gap comes from differing assumptions about how fast institutional supply replaces informal family care, which still dominates elder care in Italy. Neither assumption rests on solid empirical ground yet: comparable historical series across operators are missing, and the sector still has no shared definition of where "senior housing" ends and traditional RSA care begins.
Comparing Italy to more mature markets shows the distance. The UK, the Netherlands and Germany built a full continuum over two decades, from independent living through high-acuity RSA-equivalent care, with specialised operators, standardised performance metrics, and capital markets that price these assets much like an office or logistics portfolio. Italy starts smaller and more fragmented: religious institutions, social cooperatives and family operators still hold most of the stock, with institutional capital only recently arriving and concentrated in a handful of northern deals.
Regulation weighs on the projections more than demographics do. Regional health authorisations for new RSA facilities vary in timing and requirements, complicating any attempt to scale a single operating model nationwide within a typical fund's exit horizon. Some operators are betting on regulatory consolidation; others are building plans around permanent regional fragmentation.
The relevant investment question isn't whether demand will materialise — Istat has settled that. It's how long supply, capital and regulation take to converge on genuine institutional scale. That wide ten-year margin of error deserves scrutiny rather than dismissal as statistical noise: it describes a market still building the tools to measure itself, before it can be judged by the standards of more mature real estate segments.